CVS Health Corporation

CVS · NYSE · Stock · Healthcare
$89.81
+2.58% today
Delayed price,

What CVS Health does

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Key facts

Sector
Healthcare
Industry
Healthcare Plans
Market cap
$114.86B
P/E (ttm)
23.6
Forward P/E
10.5
Dividend yield
3.04%
Beta
0.60
Profit margin
1.2%
Employees
219,000
Headquarters
Woonsocket, RI, United States
Exchange
NYSE

Performance

1 Month
+1.1%
3 Months
-16.4%
6 Months
+16.2%
1 Year
+8.8%
5 Years
+0.8%
$69.5152-week range$110.68
Biggest setback — last 12 months
-20.0%
20 Jul 2026 → 5 Oct 2026
Fell from $107.74 to $86.16 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+53.7%
23 Mar 2026 → 20 Jul 2026
Ran from $70.08 to $107.74 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$82.37 (-8.3%)$89.81$97.91 (+9.0%)
3 Months$77.33 (-13.9%)$89.81$104.30 (+16.1%)
6 Months$72.68 (-19.1%)$89.81$110.96 (+23.6%)
12 Months$66.58 (-25.9%)$89.81$121.12 (+34.9%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 29.9%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 454 shares at $90.98 — Clark James David, SVP, Cont & Chief Acct Officer · 2026-06-29
Sold 2,478 shares at $90.98 — Newman Brian, EVP, Chief Financial Officer · 2026-06-01
Sold 7,618 shares at $90.98 — Compton-Phillips Amy, EVP, Chief Medical Officer · 2026-06-01
Sold 32,000 shares at $93.50 — AGUIRRE FERNANDO, Director · 2026-05-22
Sold 3,372,000 shares at $93.45 — ROBBINS LARRY, Director · 2026-05-21
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.